BPA Call 36C24218A0003-36C24219N0308

This is a firm-fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and associated products and services. The contract, valued at $115,930.87, is for the provision of COBAS 4800 HPV AMP/DET 960T test kits. This award does not have a set-aside designation. Roche Diagnostics has received numerous federal contract awards, including through General...

This is a $115,930.87 firm fixed-price purchase order contract awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation for COBAS 4800 HPV diagnostic equipment and associated products and services. The contract was awarded on March 7, 2017 with a completion date of the same day. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and related products that has held multiple General Services Administration (GSA) Schedule...

This is a firm fixed-price purchase order contract awarded by the Department of Defense's Medical Command (MEDCOM) to Roche Diagnostics Corporation for the provision of COBAS 4800 HPV AMP/DET testing systems and related equipment. The contract has a ceiling value of $125,119.70 and an ultimate completion date of January 27, 2017. Roche Diagnostics, which holds multiple General Services Administration (GSA) Schedule contracts for laboratory instruments and supplies, has a history of providing...

This federal contract award to Roche Diagnostics Corporation is for $3,524,806.52 to provide HPV (human papillomavirus) analyzers, reagents, and associated services to the Defense Health Agency. The contract is a firm fixed-price purchase order with a period of performance through September 30, 2028. The original pre-solicitation notice indicates the requirement is for HPV high-risk testing, detection, and genotyping services to support the Brooke Army Medical Center Department of Pathology...

This is a federal contract award to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $181,143.20, is for the delivery of HPV (Human Papillomavirus) detection kits. The contract was awarded by the U.S. Army Medical Command (MEDCOM), a Defense agency, and has a completion date of September 30, 2019. The contract is a Firm Fixed Price Purchase Order and does not...

This is a firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a leading manufacturer of in vitro diagnostics and medical laboratory equipment. The contract, valued at $134,552.15, is for the lease of Roche 4800 HPV PCR Reagents and Analyzers. The contract does not have a set-aside designation, indicating it was awarded through open competition. Roche Diagnostics Corporation is a foreign-owned, for-profit organization...

This firm fixed price purchase order for $233,116.42 was awarded by the Defense Health Agency to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to supply reagents, consumables, and controls for the Cobas 4800 testing system. The contract has a period of performance through September 30, 2024 to support testing at the place of performance in Castleton, Indiana. No set-aside designation was used for this award. The reagents, consumables, and controls will support the...

This is a firm fixed-price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostic products. The contract, valued at $497,149.96, is for the delivery of human papillomavirus (HPV) detection kits. The contract is not set aside for any type of small business. Roche Diagnostics has been awarded numerous federal contracts and task orders, including through General Services Administration (GSA) schedule...

This is a firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Agilent Technologies Inc., a manufacturer of scientific instruments and equipment. The contract is for customized reagent kits required for human papillomavirus (HPV) whole genome sequencing using Agilent's SureSelect target enrichment technology and bioinformatics support. The contract has a ceiling value of $89,678.52 and an ultimate completion date of October 27, 2018. The order was...

The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh has awarded a $85,500 firm fixed price purchase order to Seegene USA Inc. Sales Division, a foreign-owned, small disadvantaged business, for the delivery of an HPV Detection RUO Assay. This purchase order will provide the CDC Pittsburgh location with HPV test kits, reagents, and Novaplex II HPV28 detection kits to support the agency's public health mission related to HPV screening and prevention....